tetano
Editor, Senior Moderator
Microorganisms
. 2020 Nov 30;8(12):E1894.
doi: 10.3390/microorganisms8121894.
SARS-CoV-2 Inhibition by Sulfonated Compounds
Matteo Gasbarri[SUP] 1 [/SUP], Philip V'kovski[SUP] 2 3 [/SUP], Giulia Torriani[SUP] 4 [/SUP], Volker Thiel[SUP] 2 3 [/SUP], Francesco Stellacci[SUP] 1 5 [/SUP], Caroline Tapparel[SUP] 4 [/SUP], Valeria Cagno[SUP] 4 [/SUP]
Affiliations
Abstract
Severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) depends on angiotensin converting enzyme 2 (ACE2) for cellular entry, but it might also rely on attachment receptors such as heparan sulfates. Several groups have recently demonstrated an affinity of the SARS-CoV2 spike protein for heparan sulfates and a reduced binding to cells in the presence of heparin or heparinase treatment. Here, we investigated the inhibitory activity of several sulfated and sulfonated molecules, which prevent interaction with heparan sulfates, against vesicular stomatitis virus (VSV)-pseudotyped-SARS-CoV-2 and the authentic SARS-CoV-2. Sulfonated cyclodextrins and nanoparticles that have recently shown broad-spectrum non-toxic virucidal activity against many heparan sulfates binding viruses showed inhibitory activity in the micromolar and nanomolar ranges, respectively. In stark contrast with the mechanisms that these compounds present for these other viruses, the inhibition against SARS-CoV-2 was found to be simply reversible.
Keywords: SARS-CoV-2; antiviral; attachment inhibitor; heparan sulfates.
. 2020 Nov 30;8(12):E1894.
doi: 10.3390/microorganisms8121894.
SARS-CoV-2 Inhibition by Sulfonated Compounds
Matteo Gasbarri[SUP] 1 [/SUP], Philip V'kovski[SUP] 2 3 [/SUP], Giulia Torriani[SUP] 4 [/SUP], Volker Thiel[SUP] 2 3 [/SUP], Francesco Stellacci[SUP] 1 5 [/SUP], Caroline Tapparel[SUP] 4 [/SUP], Valeria Cagno[SUP] 4 [/SUP]
Affiliations
- PMID: 33265927
- DOI: 10.3390/microorganisms8121894
Abstract
Severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) depends on angiotensin converting enzyme 2 (ACE2) for cellular entry, but it might also rely on attachment receptors such as heparan sulfates. Several groups have recently demonstrated an affinity of the SARS-CoV2 spike protein for heparan sulfates and a reduced binding to cells in the presence of heparin or heparinase treatment. Here, we investigated the inhibitory activity of several sulfated and sulfonated molecules, which prevent interaction with heparan sulfates, against vesicular stomatitis virus (VSV)-pseudotyped-SARS-CoV-2 and the authentic SARS-CoV-2. Sulfonated cyclodextrins and nanoparticles that have recently shown broad-spectrum non-toxic virucidal activity against many heparan sulfates binding viruses showed inhibitory activity in the micromolar and nanomolar ranges, respectively. In stark contrast with the mechanisms that these compounds present for these other viruses, the inhibition against SARS-CoV-2 was found to be simply reversible.
Keywords: SARS-CoV-2; antiviral; attachment inhibitor; heparan sulfates.